MTCH2: Role in Water, Electrolyte and Inflammation (G23788)

Target Name: MTCH2

NCBI ID: G23788

MTCH2

MTCH2: Role in Water, Electrolyte and Inflammation

MTCH2 (SLC25A50) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the SLC family of transmembrane proteins, which are known for their ability to transport various molecules across the cell membrane. One of the unique aspects of MTCH2 is its role in the regulation of water and electrolyte balance in the body.

MTCH2 is expressed in the brain and has been shown to play a role in the regulation of water and electrolyte balance in this organ. Studies have shown that MTCH2 is expressed in various brain regions and that it is involved in the regulation of water and electrolyte balance in the brain. This is important because proper regulation of water and electrolyte balance is critical for maintaining the health and function of the brain.

MTCH2 has also been shown to play a role in the regulation of ion channels in the heart. Studies have shown that MTCH2 is expressed in the heart and that it is involved in the regulation of ion channels in this organ. This is important because proper regulation of ion channels is critical for maintaining the normal function of the heart.

In addition to its role in the regulation of water and electrolyte balance in the brain and heart, MTCH2 has also been shown to play a role in the regulation of inflammation in the body. Studies have shown that MTCH2 is expressed in various tissues and that it is involved in the regulation of inflammation. This is important because proper regulation of inflammation is critical for maintaining the health and function of various tissues in the body.

Despite its importance for various functions in the body, MTCH2 has not yet been identified as a drug target or biomarker. Further research is needed to understand the full role of MTCH2 in the regulation of water and electrolyte balance, ion channels, and inflammation in the body.

In conclusion, MTCH2 is a protein that is expressed in various tissues throughout the body. It is a member of the SLC family of transmembrane proteins and is involved in the regulation of water and electrolyte balance, ion channels, and inflammation in the body. Further research is needed to understand the full role of MTCH2 in the regulation of these functions and to identify it as a drug target or biomarker.

Protein Name: Mitochondrial Carrier 2

Functions: Protein insertase that mediates insertion of transmembrane proteins into the mitochondrial outer membrane (PubMed:36264797). Catalyzes insertion of proteins with alpha-helical transmembrane regions, such as signal-anchored, tail-anchored and multi-pass membrane proteins (PubMed:36264797). Does not mediate insertion of beta-barrel transmembrane proteins (PubMed:36264797). Also acts as a receptor for the truncated form of pro-apoptotic BH3-interacting domain death agonist (p15 BID) and has therefore a critical function in apoptosis (By similarity). Regulates the quiescence/cycling of hematopoietic stem cells (HSCs) (By similarity). Acts as a regulator of mitochondrial fusion, essential for the naive-to-primed interconversion of embryonic stem cells (ESCs) (By similarity). Acts as a regulator of lipid homeostasis and has a regulatory role in adipocyte differentiation and biology (By similarity)

The "MTCH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTCH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets